Podcasts

Sang Wu, MD, FCAP, speaker of the CAP House of Delegates, says delegates are ready to make their voices heard at this year's House of Delegates & Pathologists Leadership Summit.

M. E. (Doc) de Baca, MD, FCAP, Chair of the CAP's Council on Informatics and Pathology Innovation and a member of the CAP's Board of Governors, discusses the Council’s accomplishments in 2024 and priorities in 2025.

Kalisha Hill, MD, MBA, FCAP, FASCP, Chair of the CAP's Council on Education and a member of the CAP's Board of Governors discusses the educational wins in 2024 and Council priorities for 2025.

Guillermo Martinez-Torres, MD, FCAP, Chair of the Council on Membership and Professional Development, and a member of the CAP’s Board of Governors, discusses successes in 2024 and Council priorities for the new year.

Earle S. Collum, MD, FCAP, Chair of the CAP's Council on Accreditation, discusses the CAP's recent accreditation accomplishments and gives a preview of accreditation priorities for 2025.

Listen to CAP President Donald Karcher, MD, FCAP, share why pathologists should attend the annual Pathologists Leadership Summit and his experience advocating for pathologists and patients on Capitol Hill.

Leading the development of new proficiency testing programs for laboratories, the publication of new research, and tracking threats to public health are at the top of the scientific agenda at the College of American Pathologists.

Daniel Owens, Vice President of the Royal College of Pathologists of Australasia visits Washington, DC, to learn about the CAP's advocacy work in the nation's capital.

In this special episode, Council on Government and Professional Affairs Chair Joe Saad, MD, CPE, FCAP highlights a year of advocacy legislative wins and 2025 legislative priorities.

Cancer PathCHART is a groundbreaking initiative redefining cancer surveillance standards. Discover how Cancer PathCHART ensures more accurate data, improves cancer research, and enhances public health—all while supporting pathologists and cancer registrars in their critical roles.

Dr. Alison Van Dyke and Dr. Darrell Kirch share their journeys through mental health challenges and discuss the pervasive issue of physician burnout. With a focus on breaking the stigma, they explore the importance of seeking help, fostering open conversations, and building supportive communities. They also highlight systemic changes in medical training and healthcare environments that promote wellness.

Dr. Juanita Evans interviews Dr. Michael Williams on his journey of building a platform to amplify diverse voices in pathology. Together, they discuss the challenges and triumphs of fostering inclusivity in healthcare, highlighting how representation reshapes patient care, medical education, and the future of medicine.

Insurer interference is on the rise, creating barriers for patients to access medical care. Insurer interference often happens under the guise of cost-cutting measures for patients, but pathologists report an increase in disruptions to providing timely diagnosis and medical care for their patients.

Dr. Joel Moncur is joined by a panel of distinguished experts to discuss the groundbreaking journey of molecular proficiency testing programs, including next-generation sequencing (NGS). Drs. Wayne Grody, Karl Voelkerding, and Jason Merker discuss the impact these programs have on laboratories, patient care, and regulatory compliance, as well as the role of molecular pathology in shaping the future of health care.

Dr. Gladell Paner speaks with two GI and liver pathologists, Dr. William Chopp and Dr. John Hart, as they explore the use of the CAP hepatocellular carcinoma (HCC) reporting protocol in both academic and private practice settings.

The perception of pathology as one of medicine's best-kept secrets underscores the growing concern that medical students are not exposed to it early enough. To highlight the specialty's clinical importance, Dr. Swati Bhardwaj recently sat down with several CAP members to talk about current efforts to improve pathology education in U.S. medical schools and address gaps in histology knowledge.

Drs. David Sacks and Andy Hoofnagle discuss the history and evolution of CAP's accuracy-based proficiency testing (PT) programs, which use advanced techniques to ensure lab results meet rigorous national and international standards.

Optical genome mapping evaluates the fluorescent labeling pattern of individual DNA molecules with a resolution far exceeding conventional cytogenetic approaches like FISH and karyotyping. In this episode, Dr. Annette Kim, MD, FCAP, and Dr. Adrian Dubuc, MD, FCAP, discuss OGM's advantages, as well as some of its current limitations.

Dr. Esther Yoon, Dr. Hafsa Nebbache, and Dr. Jennifer Woo discuss their personal experiences, survey insights, and strategies for building strong relationships with clinicians, handling challenging conversations, and improving patient care through better communication.

In this episode, we will discuss the FDA's LDT final rule and the CAP’s ongoing advocacy efforts to protect pathologists and ensure patients have access to the tests they need for quality care.